LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems today announced that scientists from the University of Pennsylvania and T2 Biosystems have published a manuscript in Clinical Chemistry evaluating the use of T2MR technology for studying comprehensive hemostasis in whole blood. Titled “T2 magnetic resonance: a diagnostic platform for studying integrated hemostasis in whole blood – proof of concept,” the publication explores the potential of T2MR, an innovative and proprietary magnetic resonance-based diagnostic technology platform that may offer a rapid, sensitive and simple alternative to the current clinical standard in diagnostics.
Help employers find you! Check out all the jobs and post your resume.